Loading...
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
SIMPLE SUMMARY: Non-small cell lung cancer is the most common type of lung cancer. Anaplastic Lymphoma Kinase (ALK) rearrangements have been found in 5–6% of non-small cell lung cancers. While ALK rearranged non-small cell lung cancer is exquisitely sensitive to ALK directed targeted therapies, it i...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8004790/ https://ncbi.nlm.nih.gov/pubmed/33806977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|